Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

View source ↗

Summary

Observational study to assess safety and real-world effectiveness of finerenone in Indian adults with chronic kidney disease and type 2 diabetes; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kerendia (finerenone)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus | Status: ACTIVE_NOT_RECRUITING